Literature DB >> 8383197

Epithelial (E-) and placental (P-) cadherin cell adhesion molecule expression in breast carcinoma.

S A Rasbridge1, C E Gillett, S A Sampson, F S Walsh, R R Millis.   

Abstract

Two members of the cadherin family of intercellular adhesion molecules are found in normal breast tissue: E-(epithelial) cadherin is present in both luminal and myoepithelial cells, whereas P- (placental) cadherin is confined to myoepithelium. There is experimental evidence that loss of E-cadherin is associated with increased invasiveness of malignant cells in vitro, which stimulated us to examine the presence and distribution of E- and P-cadherin in breast carcinomas by means of immunohistochemical staining. E-Cadherin was present in all in situ and invasive ductal carcinomas examined, although it had a patchy distribution and the staining was of variable intensity. However, in 83 per cent of invasive lobular carcinomas and all lobular carcinomas in situ there was complete loss of E-cadherin expression. In the remaining 17 per cent of invasive lobular tumours, E-cadherin appeared to have an abnormal distribution within the cytoplasm with variable expression on the cell membrane. P-Cadherin, by contrast, was absent from all benign breast luminal epithelium and 25 carcinomas of ductal and lobular type. It was found in only one carcinoma of lobular type. We suggest that loss of cell-cell adhesion mediated by E-cadherin plays a part in the characteristic morphology of lobular carcinomas.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8383197     DOI: 10.1002/path.1711690211

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  52 in total

Review 1.  Cadherin junctions in mammary tumors.

Authors:  M J Wheelock; A P Soler; K A Knudsen
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-07       Impact factor: 2.673

2.  Disparate E-cadherin mutations in LCIS and associated invasive breast carcinomas.

Authors:  K M Rieger-Christ; J A Pezza; J M Dugan; J W Braasch; K S Hughes; I C Summerhayes
Journal:  Mol Pathol       Date:  2001-04

3.  Repression of E-cadherin by the polycomb group protein EZH2 in cancer.

Authors:  Q Cao; J Yu; S M Dhanasekaran; J H Kim; R-S Mani; S A Tomlins; R Mehra; B Laxman; X Cao; J Yu; C G Kleer; S Varambally; A M Chinnaiyan
Journal:  Oncogene       Date:  2008-09-22       Impact factor: 9.867

Review 4.  Tissue architecture: the ultimate regulator of epithelial function?

Authors:  C Hagios; A Lochter; M J Bissell
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1998-06-29       Impact factor: 6.237

5.  Expression of E-cadherin in oesophageal carcinomas from the UK and China: disparities in prognostic significance.

Authors:  W G Jian; S J Darnton; K Jenner; L J Billingham; H R Matthews
Journal:  J Clin Pathol       Date:  1997-08       Impact factor: 3.411

6.  Co-expression of E-cadherin and alpha-catenin molecules in colorectal cancer.

Authors:  T Kitagawa; K Matsumoto; A Nagafuchi; S Tsukita; H Suzuki
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

7.  Expression of E-Cadherin in breast carcinomas and its association with other biological markers - a prospective study.

Authors:  B Rekhi; A Bansal; D Bhatnagar; S Saxena
Journal:  Indian J Surg Oncol       Date:  2010-08-07

8.  Expression of E-cadherin, alpha-catenin, and beta-catenin in tubulolobular carcinoma of the breast.

Authors:  Hajime Kuroda; Jun-Ichi Tamaru; Ikuya Takeuchi; Kiyoshi Ohnisi; Goi Sakamoto; Akiko Adachi; Kou Kaneko; Shinji Itoyama
Journal:  Virchows Arch       Date:  2006-03-15       Impact factor: 4.064

9.  Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas.

Authors:  R Moll; M Mitze; U H Frixen; W Birchmeier
Journal:  Am J Pathol       Date:  1993-12       Impact factor: 4.307

10.  E-cadherin gene mutations in human gastric carcinoma cell lines.

Authors:  T Oda; Y Kanai; T Oyama; K Yoshiura; Y Shimoyama; W Birchmeier; T Sugimura; S Hirohashi
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.